ModelEdge

InMed Pharmaceuticals Inc.
INM
Filing Type425
Filing Date7/9/2026
Updated7/10/26, 2:04 PM

Filing

425
Earnings Release

Exhibits

425Prospectus Filed Pursuant to Rule 425
EX-2.2AMENDMENT NO.1 TO THE AGREEMENT AND PLAN OF MERGER AND REORGANIZATION, DATED AS OF JULY 6, 2026, BY AND AMONG INMED PHARMACEUTICALS INC., INDIGO MERGER SUB CORP., INDIGO MERGER SUB II, LLC AND MENTARI THERAPEUTICS, INC.
EX-99.1PRESS RELEASE, ISSUED ON JULY 6, 2026
GRAPHICGraphic